user

Association between GvHD and nivolumab in the FDA adverse event reporting system

被引：7
|
作者：
Oshima, Y. [1 ]
Tanimoto, T. [2 ]
Yuji, K. [1 ]
Tojo, A. [1 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Tokyo, Japan
[2] Tokiwa Fdn, Jyoban Hosp, Fukushima, Japan
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 10期
关键词：
HOST-DISEASE LETHALITY; LYMPHOMA; BLOCKADE; TRANSPLANTATION; EFFICACY;
D O I：
10.1038/bmt.2017.158
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1463 / 1464
页数：2
相关论文
共 50 条
  • [21] An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
    Geetha Iyer
    Sathiya Priya Marimuthu
    Jodi B. Segal
    Sonal Singh
    [J]. Drug Safety, 2017, 40 : 799 - 808
  • [22] A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab
    Chen, Zepeng
    Li, Ming
    Li, Shuzhen
    Li, Yuxi
    Wu, Junyan
    Qiu, Kaifeng
    Yu, Xiaoxia
    Huang, Lin
    Chen, Guanghui
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (04) : 339 - 342
  • [23] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    [J]. HELIYON, 2024, 10 (17)
  • [24] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
    Pankdeep Chhabra
    Xing Chen
    Sheila R. Weiss
    [J]. Drug Safety, 2013, 36 : 1117 - 1123
  • [25] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
    Chhabra, Pankdeep
    Chen, Xing
    Weiss, Sheila R.
    [J]. DRUG SAFETY, 2013, 36 (11) : 1117 - 1123
  • [26] IN VIDEO, FDA URGES ADVERSE EVENT REPORTING
    Cima, Greg
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 259 (03): : 223 - 223
  • [27] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system
    Huang, Qing
    Wu, Yuanbin
    Li, Huimin
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [29] Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
    Byskov, Pernille Kahler
    Baden, Christoffer Storm
    Andersen, Jon Traerup
    Jimenez-Solem, Espen
    Olsen, Ramus Huan
    Gade, Christina
    Lausten-Thomsen, Ulrik
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] REPORTING FREQUENCY OF QT-INTERVAL ABNORMALITIES IN THE FDA ADVERSE EVENT REPORTING SYSTEM (FDA_AERS)
    Raschi, E.
    Poluzzi, E.
    Koci, A.
    De Ponti, F.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 84 - 84
12345